A route to new cancer therapies: the FA pathway is essential in BRCA1- or BRCA2-deficient cells

Christophe Lachaud, John Rouse
2016 Nature Structural & Molecular Biology  
doi:10.1038/nsmb.3276 pmid:27487393 fatcat:hhqym5d4gveo5j3ductm25mzo4